Justin Meiklem

Vancouver, British Columbia and Rehovot, Israel – March 6, 2025 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (NASDAQ: BHST), a company pioneering its patented Botanical Synthesis technology platform, today announcedthat management has been invited to attend the 37th Annual Roth Conference taking place on March 16-18, 2025. CEO Ilan Sobel is scheduled to host […]

 Non-Alcoholic Fatty Liver Disease (NAFLD) Affects 30-40% of U.S. Adults, Driving Significant Market Need for BioHarvest’s Future Olive Cell Product targeting Liver Health  Vancouver, British Columbia and Rehovot, Israel – March 4, 2025 BioHarvest Sciences Inc.,  (Nasdaq: BHST) (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology process, today announced new ‘in

Commercial success of VINIA validates the power of BioHarvest’s patented Botanical Synthesis technology to produce valuable plant-based Compounds at industrial scale Vancouver, British Columbia and Rehovot, Israel – February 18, 2025– BioHarvest Sciences Inc.,  (Nasdaq: BHST) (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology process, today announced that its Red Grape

Vancouver, British Columbia and Rehovot, Israel – February 12, 2025 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (Nasdaq: BHST) (CSE: BHSC)  (FSE: 8MV0), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to present at the WeBull Consumer Stocks Virtual Webinar taking place on February 18, 2025.

Vancouver, British Columbia and Rehovot, Israel – February 10, 2025– BioHarvest Sciences Inc.,  (Nasdaq: BHST) (CSE: BHSC)  (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology process, today announced that that it has applied and received approval for a voluntary delisting of its common shares from the Canadian Securities Exchange (“CSE”). The

Veteran Technology Leader Brings 25+ Years of Financial and Capital Markets Experience to the Board Vancouver, British Columbia and Rehovot, Israel – January 22, 2025– BioHarvest Sciences Inc.,  (Nasdaq: BHST) (CSE: BHSC)  (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology process, today announced that Mr. Sharon Malka has agreed to serve